Showing results (1521-1530 of 1,868) with videos related to

Sort By:
Pageof 187
Journal of Medical Microbiology|February 12, 2000
Development and evaluation of a solid-phase enzyme immunoassay based on Andes hantavirus recombinant nucleoproteinP J Padula, C M Rossi, M O Della Valle, et al.
Scientific Reports|May 4, 2017
In-Vivo Efficacy of Chloroquine to Clear Asymptomatic Infections in Mozambican Adults: A Randomized, Placebo-controlled Trial with Implications for Elimination StrategiesBeatriz Galatas, Lidia Nhamussua, Baltazar Candrinho, et al.
International Ophthalmology|September 10, 2024
Adalimumab to treat noninfectious pediatric chronic anterior uveitis: a case seriesRaul E Ruiz-Lozano, Hazem M Mousa, Matias Soifer, et al.
International Journal of Chronic Obstructive Pulmonary Disease|October 1, 2019
Progression of physical inactivity in COPD patients: the effect of time and climate conditions - a multicenter prospective cohort studyAfroditi K Boutou, Yogini Raste, Heleen Demeyer, et al.
Experimental and Clinical Psychopharmacology|December 28, 1999
EEG, physiology, and task-related mood fail to resolve across 31 days of smoking abstinence: relations to depressive traits, nicotine exposure, and dependenceD G Gilbert, F J McClernon, N E Rabinovich, et al.
Biochimica Et Biophysica Acta. Molecular Cell Research|March 26, 2019
Dual knockdown of Galectin-8 and its glycosylated ligand, the activated leukocyte cell adhesion molecule (ALCAM/CD166), synergistically delays in vivo breast cancer growthFátima Ferragut, Alejandro J Cagnoni, Lucas L Colombo, et al.
The FEBS Journal|March 14, 2013
NMR mapping of RANTES surfaces interacting with CCR5 using linked extracellular domainsEinat Schnur, Naama Kessler, Yuri Zherdev, et al.
Frontiers in Immunology|March 17, 2018
Galectins in Intestinal Inflammation: Galectin-1 Expression Delineates Response to Treatment in Celiac Disease PatientsVictoria Sundblad, Amado A Quintar, Luciano G Morosi, et al.
Angiogenesis|October 2, 2020
Characterization of a neutralizing anti-human galectin-1 monoclonal antibody with angioregulatory and immunomodulatory activitiesJuan M Pérez Sáez, Pablo F Hockl, Alejando J Cagnoni, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2014
OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesisLucile Astorgues-Xerri, Maria E Riveiro, Annemilaï Tijeras-Raballand, et al.
Pageof 187